On ADHD Medication & Addiction
A history of substance abuse often precludes a young patient with ADHD from receiving a prescription for stimulant medication. Itβs a common precaution, but new research suggests withholding treatment may do more harm than good. In fact, withholding ADHD treatment may put young people at greater risk of health problems and other adverse outcomes.
A national study led by researchers at the Penn State College of Medicine found a striking treatment deficit among adolescents and young adults diagnosed with both ADHD and substance abuse disorder (SUD). Published in the Journal of the American Academy of Child and Adolescent Psychiatry, the study analyzed medical records from more than 1.2 million people ages 15 to 25 diagnosed with ADHD. Of those, nearly one in four also had an SUD.
When a young person with ADHD received an SUD diagnosis, they were significantly less likely to be prescribed ADHD medication, the study found. Ongoing stimulant prescriptions dropped by roughly 15% among this group, and new stimulant prescriptions fell by more than 17%.
Young people who continued receiving ADHD treatment had meaningfully better outcomes, with fewer emergency room visits, fewer hospitalizations, fewer accidental overdoses, and fewer suicidal thoughts and attempts. They were also more likely to continue with psychiatric care. Most strikingly, ADHD treatment was associated with an approximately 30% lower risk of death over five years.
[Watch: ADHD Treatment and Substance Use Problems β The Latest Research on Stimulants & SUD]
Benefits were seen with both central nervous system stimulants (e.g., Adderall, Ritalin) and non-stimulants (e.g., Strattera), though stimulants were associated with even greater reductions in certain adverse outcomes.
These findings directly challenge the assumption that stimulant treatment worsens substance use-related problems.
The ADHD-SUD Connection
Research suggests that up to half of people with ADHD may develop a substance use disorder at some point in their lives due to genetics and neurobiology. Impulsivity, poor emotional regulation, and difficulty thinking through consequences can increase vulnerability to substance use. Without effective treatment, some young people discover that substances temporarily quiet the mental restlessness or emotional pain that ADHD can cause.
When ADHD and SUD occur together, the stakes are significantly higher: We see elevated rates of emergency room visits, hospitalizations, accidental overdose, suicidal thoughts, suicide attempts, and higher mortality risk. Effective treatment is not optional. It is urgent.
[Self-Test: Could You Have a Substance Use Disorder?]
The Risks of Withholding Medication
Stimulants typically produce significant symptom improvement. However, they are also controlled substances with documented potential for misuse and dependence, a concern that becomes even more significant when substance use is already in the picture. Many families and clinicians share this unease, and it helps to explain why providers often hesitate to prescribe stimulants once substance use is diagnosed.
However, when ADHD goes untreated, serious consequences may follow. Untreated ADHD can drive academic failure, emotional dysregulation, and low self-esteem, all of which can fuel substance misuse. Effective ADHD treatment interrupts that cycle. Better symptom control helps young people make safer decisions, stay engaged in school or work, and participate more consistently in recovery programs. For some, ADHD medication may also reduce the urge to self-medicate.
The Bottom Line
While any controlled substance should be prescribed with caution to patients struggling with substance use, an SUD diagnosis should not automatically end access to evidence-based ADHD treatment. Every patient is different, and the right approach depends on the individual. What matters most is that the conversation between doctor and patient remains open, treatment is actively monitored, and care is coordinated across mental health and addiction specialists when needed.
Questions to ask a treatment team include:
- What are the risks and benefits of each medication option?
- How will treatment be monitored safely?
- What warning signs should we heed?
The goal is not just symptom control; it is promoting safety, restoring functioning, and giving young people a genuine chance at a healthier future. If you have questions about your own treatment or your childβs, bring them to your clinicians. Advocate for comprehensive care. The evidence is on your side.
When Drug Testing Is Routine
Some ADDitude readers have told us that they were required to submit to regular drug testing as a condition of continuing to receive their ADHD stimulant medication prescription. Among the reasons: to monitor adherence, prevent misuse, or comply with controlled-substance monitoring guidelines.
Here are a few of the comments they shared:
βThe policy from my doctor was that I had to sign an agreement before she would prescribe medication, and if she ever felt that I was abusing it, she would give me a test. I havenβt been asked to take a test and itβs been three years since I signed on.β
βIt costs $150 every time they ask me for a urine test. Itβs ridiculous.β
βI have to do a drug screen once a year in order to refill my Adderall prescription.β
βAs an adult, this policy has been required by my doctor to confirm that I am, in fact, taking my medicine. However, when I was younger and seeing a pediatrician, it was never required for me.β
Stimulant Treatment and SUD : Next Steps
- Watch: Substance Use Disorder and ADHD β Safe, Effective Treatment Options
- Read: The Damaging Effects of Cannabis on the ADHD Brain
- Read: Substance Use Disorders and ADHD β 5 Key Facts and Additional Resources
Raman Baweja, M.D., is a professor of psychiatry and behavioral health and public health sciences at the Penn State College of Medicine in Hershey, Pennsylvania.
ADDITUDE IS HUMAN
Artificial intelligence does not create or edit any written content published by ADDitude. Our editorial team is 100% human, and our mission is simple: listen to and serve our readers with hand-crafted, expert-informed resources. To support ADDitude, please consider subscribing. Your readership and support help make our commitment possible. Thank you.
